S. Yla-herttuala, Cardiovascular gene therapy with vascular endothelial growth factors, Gene, vol.525, issue.2, pp.217-219, 2013.

S. Banquet, E. Gomez, L. Nicol, F. Edwards-levy, J. P. Henry et al., Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, issue.9, pp.1059-1069, 2011.

N. Krankel, T. F. Luscher, and U. Landmesser, Endothelial progenitor cells'' as a therapeutic strategy in cardiovascular disease, Curr Vasc Pharmacol, vol.10, issue.1, pp.107-124, 2011.

M. P. Santini and N. Rosenthal, Myocardial regenerative properties of macrophage populations and stem cells, J Cardiovasc Transl Res, vol.5, issue.5, pp.700-712, 2012.

S. Frantz, U. Hofmann, D. Fraccarollo, A. Schafer, S. Kranepuhl et al., Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction, FASEB J, vol.27, issue.3, pp.871-881, 2012.

M. L. Novak and T. J. Koh, Phenotypic transitions of macrophages orchestrate tissue repair, Am J Pathol, vol.183, issue.5, pp.1352-1363, 2013.

D. M. Mosser and J. P. Edwards, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, vol.8, issue.12, pp.958-969, 2008.

S. Frantz and M. Nahrendorf, Cardiac macrophages and their role in ischemic heart disease, Cardiovasc Res, vol.102, issue.2, pp.240-248, 2014.

B. D. Fleming and D. M. Mosser, Regulatory macrophages: setting the threshold for therapy, Eur J Immunol, vol.41, issue.9, pp.2498-2502, 2011.

M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger et al., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J Exp Med, vol.204, issue.12, pp.3037-3047, 2007.

P. R. Sanberg, D. H. Park, N. Kuzmin-nichols, C. E. Hossne, N. A. Buffolo et al., Monocyte transplantation for neural and cardiovascular ischemia repair, J Cell Mol Med, vol.14, issue.3, pp.553-563, 2009.

M. Besnier, A. Galaup, L. Nicol, J. P. Henry, D. Coquerel et al., Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice, FASEB J, vol.28, issue.8, pp.3351-3361, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02142777

R. Hurteaux, F. Edwards-levy, D. Laurent-maquin, and M. C. Levy, Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide, Eur J Pharm Sci, vol.24, issue.2-3, pp.187-197, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00069190

A. Luttun, M. Tjwa, L. Moons, Y. Wu, A. Angelillo-scherrer et al., Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1, Nat Med, vol.8, issue.8, pp.831-840, 2002.

C. B. Schmidt-weber, M. Rittig, E. Buchner, I. Hauser, I. Schmidt et al., Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes, J Leukoc Biol, vol.60, issue.2, pp.230-244, 1996.

S. E. Chambers, C. L. O'neill, O. Doherty, T. M. Medina, R. J. Stitt et al., The role of immune-related myeloid cells in angiogenesis, Immunobiology, vol.218, issue.11, pp.1370-1375, 2013.

E. Zajac, B. Schweighofer, T. A. Kupriyanova, A. Juncker-jensen, P. Minder et al., Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9, Blood, vol.122, issue.25, pp.4054-4067, 2013.

C. Sunderkotter, K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg, Macrophages and angiogenesis, J Leukoc Biol, vol.55, issue.3, pp.410-422, 1994.

C. Guo, A. Buranych, D. Sarkar, P. B. Fisher, and X. Y. Wang, The role of tumor-associated macrophages in tumor vascularization, Vasc Cell, vol.5, issue.1, p.20, 2013.

C. Stockmann, A. Doedens, A. Weidemann, N. Zhang, and N. Takeda,

J. I. Greenberg, D. A. Cheresh, and R. S. Johnson, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, vol.456, issue.7223, pp.814-818, 2008.

N. Brechot, E. Gomez, M. Bignon, J. Khallou-laschet, M. Dussiot et al., Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice, PLoS One, vol.3, issue.12, p.3950, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00343251

G. Andres, D. Leali, S. Mitola, D. Coltrini, M. Camozzi et al., A pro-inflammatory signature mediates FGF2-induced angiogenesis, J Cell Mol Med, vol.13, issue.8B, pp.2083-2108, 2009.

T. Kaga, H. Kawano, M. Sakaguchi, T. Nakazawa, Y. Taniyama et al., Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor, Vascul Pharmacol, vol.57, issue.1, pp.3-9, 2012.

C. D. Ley, M. W. Olsen, E. L. Lund, and P. E. Kristjansen, Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay, Microvasc Res, vol.68, issue.3, pp.161-168, 2004.

G. Seghezzi, S. Patel, C. J. Ren, A. Gualandris, G. Pintucci et al., Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis, J Cell Biol, vol.141, issue.7, pp.1659-1673, 1998.

J. C. Tille, J. Wood, S. J. Mandriota, C. Schnell, S. Ferrari et al., Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF-and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro, J Pharmacol Exp Ther, vol.299, issue.3, pp.1073-1085, 2001.

M. Murakami, L. T. Nguyen, K. Hatanaka, W. Schachterle, P. Y. Chen et al., FGF-dependent regulation of VEGF receptor 2 expression in mice, J Clin Invest, 2011.

D. Li, C. Zhang, F. Song, I. Lubenec, Y. Tian et al., VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration, Microvasc Res, vol.77, issue.2, pp.134-142, 2009.

E. Van-belle, B. Witzenbichler, D. Chen, M. Silver, L. Chang et al., Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis, Circulation, vol.97, issue.4, pp.381-390, 1998.

X. Xin, S. Yang, G. Ingle, C. Zlot, L. Rangell et al., Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo, Am J Pathol, vol.158, issue.3, pp.1111-1120, 2001.

J. Wojta, C. Kaun, J. M. Breuss, Y. Koshelnick, R. Beckmann et al., Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells, Lab Invest, vol.79, issue.4, pp.427-438, 1999.

Y. Carmi, S. Dotan, P. Rider, I. Kaplanov, M. R. White et al., The role of IL-1beta in the early tumor cell-induced angiogenic response, J Immunol, vol.190, issue.7, pp.3500-3509, 2013.

K. L. Spiller, R. R. Anfang, K. J. Spiller, J. Ng, K. R. Nakazawa et al., The role of macrophage phenotype in vascularization of tissue engineering scaffolds, Biomaterials, vol.35, issue.15, pp.4477-4488, 2014.

A. C. Aplin, G. Ligresti, E. Fogel, P. Zorzi, K. Smith et al., Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors, Angiogenesis, vol.17, issue.1, pp.147-161, 2014.